Propagation of yeast prions

Nature Reviews Molecular Cell Biology

Volumn 4, Issue 11, 2003, Pages 878-889

  Tuite, Mick F ^a   Cox, Brian S ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; HEAT SHOCK PROTEIN 104; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; PRION PROTEIN;

BIOLISTIC TRANSFORMATION; CONFORMATIONAL TRANSITION; FUNGAL METABOLISM; HUMAN; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; SACCHAROMYCES CEREVISIAE; YEAST;

AMINO ACID SEQUENCE; HEAT-SHOCK PROTEINS; MOLECULAR SEQUENCE DATA; PRIONS; PROTEIN CONFORMATION; YEASTS;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0242636317     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1247     Document Type: Review

References (131)

1. Prusiner, S. B., Scott, M. R., DeArmond, S. J. & Cohen, F. E. Prion protein biology. Cell 93, 337-348 (1998).
2. Aguzzi, A., Montrasio, F. & Kaeser, P. S. Prions: health scare and biological challenge. Nature Rev. Mol. Cell Biol. 2, 118-126 (2001).
3. +] determinants might be prions and provide genetic data that both support this hypothesis for [URE3] and identify the underlying prion protein as Ure2.
4. Coustou, V., Deleu, C., Saupe, S. & Begueret, J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora ansenna behaves as a prion analog. Proc. Natl Acad. Sci. USA 94, 9773-9778 (1997).
5. Eaglestone, S. S., Cox, B. S. & Tuite, M. F. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J. 18, 1974-1981 (1999).
6. True, H. L. & Lindquist, S. L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477-483 (2000).
7. Uptain, S. M. & Lindquist, S. Prions as protein-based genetic elements. Ann. Rev. Microbiol. 56, 703-741 (2002).
8. Wickner, R. B. et al. Yeast prions act as genes composed of self-propagating protein amyloids. Adv. Protein Chem. 57, 313-334 (2001).
9. Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (1982).
10. Cox, B. S. [PSI], a cytoplasmic suppressor of super-suppressors in yeast. Heredity 20, 505-521 (1965).
11. Lacroute, F. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J. Bacteriol. 106, 519-522 (1971).
12. Aigle, M. & Lacroute, F. Genetical aspects of [URE3], a non-Mendelian, cytoplasmically-inherited mutation in yeast. Mol. Gen. Genet. 136, 327-335 (1975).
13. Cox, K. H. et al. Saccharomyces cerevisiae GATA sequences function as TATA elements during nitrogen catabolite repression and when Gln3p is excluded from the nucleus by overproduction of Ure2p. J. Biol. Chem. 275, 17611-17618 (2000).
14. Kulkarni, A. A., Abul-Hamd, A. T., Rai, R., El Berry, H. & Cooper, T. G. Gln3p nuclear localization and interaction with Ure2p in Saccharomyces cerevisiae. J. Biol. Chem. 276, 32136-32144 (2001).
15. Cox, B. S. A recessive lethal super-suppressor mutation in yeast and other psi phenomena. Heredity 26, 211-232 (1971).
16. +] cells, the authors also show for the first time that the Sup35 prion-forming domain is modular and can transfer prion properties to another protein - in this case, green fluorescent protein (see also reference 17).
17. +]-dependent manner. Also provides data to support the theory that Hsp104 disrupts these aggregates to ensure effective transmission of the prion form of Sup35 during cell division (see also reference 16).
18. Stansfield, I. et al. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J. 14, 4365-4373 (1995).
19. Sondheimer, N. & Lindquist, S. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 5, 163-172 (2000).
20. +] effect (see also reference 73).
21. Prusiner, S. B. et al. Further purification and characterization of scrapie prions. Biochemistry 21, 6942-6950 (1982).
22. Prusiner, S. B. et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349-358 (1983).
23. Masison, D. C. & Wickner, R. B. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270, 93-95 (1995). The authors show that the Ure2 protein has a 'prion-inducing domain' at its amino terminus that is functionally distinct from the remainder of the protein and show a role for this domain in the regulation of nitrogen assimilation.
24. Taylor, K. L., Cheng, N., Williams, R. W., Steven, A. C. & Wickner, R. B. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283, 1339-1343 (1999).
25. Schlumpberger, M. et al. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein. Protein Sci. 9, 440-451 (2000).
26. - a heritable prion-like factor of S. cerevisiae. Cell 89, 811-819 (1997). By showing that Sup35 in vitro forms protein fibres that have all the biophysical properties of an amyloid, the authors establish that the yeast prion shows remarkably similar properties to a number of proteins implicated in human amyloidoses including transmissible spongiform encephalopathies.
27. King, C. Y. et al. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl Acad. Sci. USA 94, 6618-6622 (1997).
28. Paushkin, S. V., Kushnirov, V. V., Smirnov, V. N. & Ter-Avanesyan, M. D. In vitro propagation of the prion-like state of yeast Sup35 protein. Science 277, 381-383 (1997). Provides evidence that the aggregated form of Sup35 can seed the polymerization of soluble Sup35 through several consecutive cycles, thereby providing support for the 'protein-only' hypothesis for prion propagation in yeast.
29. +] factor by in vitro-converted Sup35 protein. Science 289, 595-599 (2000).
30. Maddelein, M. L., Dos Reis, S., Duvezin-Caubet, S., Coulary-Salin, B. & Saupe, S. J. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl Acad. Sci. USA 99, 7402-7407 (2002).
31. Michelitsch, M. D. & Weissman, J. S. A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc. Natl Acad. Sci. USA 97, 11910-11915 (2000).
32. -] 'prions' that are cross-transmissible and susceptible beyond a species barrier through a quasi-prion state. Mol. Cell 7, 1121-1130 (2001).
33. +] prion are in some way linked (see also reference 53).
34. Masison, D. C., Maddelein, M. L. & Wickner, R. B. The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. Proc. Natl Acad. Sci. USA 94, 12503-12508 (1997).
35. Tuite, M. F. Yeast prions and their prion-forming domain. Cell 100, 289-292 (2000).
36. Li, L. & Lindquist, S. Creating a protein-based element of inheritance. Science 287, 661-664 (2000).
37. Maddelein, M. L. & Wickner R. B. Two prion-inducing regions of Ure2p are non-overlapping. Mol. Cell. Biol. 19, 4516-4524 (1999).
38. Baxa, U., Speransky, V., Steven, A. C. & Wickner, R. B. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein Proc. Natl Acad. Sci. USA 99, 5253-5260 (2002).
39. -] mutations in Saccharomyces cerevisiae. Genet. Res. 37, 173-182 (1981).
40. Liu, J. J. & Lindquist, S. Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast. Nature 400, 573-576 (1999).
41. +] prions and conclude that these different states might be analogous to the 'strains' reported for mammalian prions.
42. Derkatch, I. L., Bradley, M. E., Zhou, P., Chernoff, Y. O. & Liebman, S. W. Genetic and environmental factors affecting the de novo appearance of the PSI+ prion in Saccharomyces cerevisiae. Genetics 147, 507-519 (1997).
43. Fernandez-Bellot, E., Guillemet, E. & Cullin, C. The yeast prion [URE3] can be greatly induced by a functional mutated URE2 allele. EMBO J. 19, 3215-3222 (2000).
44. Parham, S. N., Resende, C. G. & Tuite, M. F. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J. 20, 2111-2119 (2001).
45. +]. Proc. Natl Acad. Sci. USA 99, 16446-16453 (2002).
46. DePace, A. H., Santoso, A., Hillner, P. & Weissman, J. S. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93, 1241-1252 (1998).
47. Young, C. S. H. & Cox, B. S. Extrachromosomal elements in a super-suppression system of yeast. I. A nuclear gene controlling the inheritance of the extrachromosomal elements. Heredity 26, 413-422 (1971).
48. Kochneva-Pervukhova, N. V. et al. Mechanism of inhibition of Psi(+) prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein. EMBO J. 17, 5805-5810 (1998).
49. McCready, S. J., Cox, B. S. & McLaughlin, C. S. The extrachromosomal control of nonsense suppression in yeast: an analysis of the elimination of [psi+] in the presence of a nuclear gene PNM. Mol. Gen. Genet. 150, 265-270 (1977).
50. Kushnirov, V. V. et al. Nucleotide sequence of the Sup2 (Sup35) Gene of Saccharomyces cerevisiae. Gene 66, 45-54 (1988).
51. Wilson, P. G. & Culbertson, M. R. SUF12 suppressor protein of yeast. A fusion protein related to the EF-1 family of elongation factors. J. Mol. Biol. 199, 559-573 (1988).
52. Weissmann, C. Molecular genetics of transmissible spongiform encephalopathies. J. Biol. Chem. 274, 3-6 (1999).
53. Doel, S. M., McCready, S. J., Nierras, C. R. & Cox, B. S. The dominant PNM2 mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137, 659-670 (1994).
54. Santoso, A., Chien, P., Osherovich, L. Z. & Weissman, J. S. Molecular basis of a yeast prion species barrier. Cell 100, 277-288 (2000). The authors show that Sup35 from related yeast species cannot be seeded by the Saccharomyces cerevisiae Sup35 prion, thereby showing that a 'species barrier' exists for yeast prion propagation.
55. Chien, P. & Weissman, J. S. Conformational diversity in a yeast prion dictates its seeding specificity. Nature 410, 223-227 (2001).
56. Prusiner, S. B. & Scott, M. R. Genetics of prions. Ann. Rev. Genet. 31, 139-175 (1997).
57. Chiesa, R., Piccardo, P., Ghetti, B. & Harris, D. A. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21, 1339-1351 (1998).
58. Flechsig, E. et al. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27, 399-408 (2000).
59. Pan, K. M. et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA 90, 10962-10966 (1993).
60. Dobson, C. M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24, 329-332 (1999).
61. Kocisko, D. A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471-474 (1994).
62. Come, J. H., Fraser, P. E. & Lansbury, P. T. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA 90, 5959-5963 (1993).
63. Griffith, J. S. Self-replication and scrapie. Nature 215, 1043-1044 (1967).
64. Prusiner, S. B. Molecular biology of prion diseases. Science 252, 1515-1522 (1991).
65. Thual, C. et al. Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2. J. Biol. Chem. 274, 13666-13674 (1999).
66. Seno, T. R. et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317-1321 (2000),
67. Xu, S., Bevis, B. & Arnsdorf, M. F. The assembly of amyloidogenic yeast sup35 as assessed by scanning (atomic) force microscopy: an analogy to linear colloidal aggregation? Biophys. J. 81, 446-454 (2001).
68. Perutz, M. F. Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci. 24, 58-63 (1999).
69. Perutz, M. F., Johnson, T., Suzuki, M. & Finch, J. T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl Acad. Sci. USA 91, 5355-5358 (1994).
70. Perutz, M. F., Pope, B. J., Owen, D., Wanker, E. E. & Scherzinger, E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques. Proc. Natl Acad. Sci. USA 99, 5596-5600 (2002).
71. Balbirnie, M., Grothe, R. & Eisenberg, D. S. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated β-sheet structure for amyloid. Proc. Natl Acad. Sci. USA 98, 2375-2380 (2001).
72. -]: a two-prion system in yeast? EMBO J. 19, 1942-1952 (2000).
73. +] effect.
74. Scheibel, T. & Lindquist, S. L. The role of conformational flexibility in prion propagation and maintenance for Sup35p. Nature Struct Biol. 8, 958-962 (2001).
75. Gazit, E. Global analysis of tandem aromatic octapeptide repeats: the significance of the aromatic-glycine motif. Bioinformatics 18, 880-883 (2002).
76. Bousset, L., Thomson, N. H., Radford, S. E. & Melki, R. The yeast prion Ure2p retains its native α-helical conformation upon assembly into protein fibrils in vitro. EMBO J. 21, 2903-2911 (2002).
77. Speransky, V. V., Taylor, K. L., Edskes, H. K., Wickner, R. B. & Steven, A. C. Prion filament networks in [URE3] cells of Saccharomyces cerevisiae. J. Cell Biol. 153, 1327-1336 (2001).
78. Bruce, M. E. Scrapie strain variation and mutation. Brit. Med. Bull. 49, 822-838 (1993).
79. Prusiner, S. B. Prions. Proc Natl. Acad. Sci. USA 95, 13363-13383 (1998).
80. Caughey, B., Raymond, G. J. & Bessen, R. A. Strain-dependent differences in β-sheet conformations of abnormal prion protein. J. Biol. Chem. 273, 32230-32235 (1998).
81. Bessen, R. A. & Marsh, R. F. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68, 7859-7868 (1994).
82. +] are distinguished by their efficiencies of prion-mediated conformational conversion. EMBO J. 20, 6236-6245 (2001).
83. +] prion generation in yeast: characterization of the 'strain' difference. Yeast 18, 489-497 (2001).
84. Schlumpberger, M., Prusiner, S. B. & Herskowitz, I. Induction of distinct [URE3] yeast prion strains. Mol. Cell. Biol. 21, 7035-7046 (2001).
85. Kushnirov, V. V., Kochneva-Pervukhova, N., Chechenova, M. B., Frolova, N. S. & Ter-Avanesyan, M. D. Prion properties of the Sup35 protein of yeast Pichia methanolica. EMBO J. 19, 324-331 (2000).
86. DePace, A. H. & Weissman, J. S. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers. Nature Struct. Biol. 9, 389-396 (2002).
87. Tuite, M. F. & Cox, B. S. Ultraviolet mutagenesis studies of [psi], a cytoplasmic determinant of Saccharomyces cerevisiae. Genetics 95, 611-630 (1980).
88. +] prion.
89. Moriyama, H., Edskes, H. K. & Wickner, R. B. [URE3] prion propagation in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydi1p. Mol. Cell. Biol. 20, 8916-8922 (2000).
90. Wegrzyn, R. D., Bapat, K., Newnam, G. P., Zink, A. D. & Chernoff, Y. O. Mechanism of prion loss after Hsp104 inactivation in yeast. Mol. Cell. Biol. 21, 4656-4669 (2001).
91. Parsell, D. A., Kowal, A. S., Singer, M. A. & Lindquist, S. Protein disaggregation mediated by heat-shock protein Hsp104. Nature 372, 475-478 (1994).
92. Glover, J. R. & Lindquist, S. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94, 73-82 (1998).
93. Ogura, T. & Wilkinson, A. J. AAA+ superfamily ATPases: common structure - diverse function. Genes Cells 6, 575-597 (2001).
94. Parsell, D., A., Sanchez, Y., Stitzel, J. D. & Lindquist, S. Hsp104 is a highly conserved protein with two essential nucleotide-binding sites. Nature 353, 270-273 (1991).
95. Cashikar, A. G. et al. Defining a pathway of communication from the C-terminal peptide binding domain to the N-terminal ATPase domain in a AAA protein. Mol. Cell 9, 751-760 (2002).
96. Parsell, D. A., Kowal, A. S. & Lindquist, S. Saccharomyces cerevisiae Hsp104 protein. Purification and characterization of ATP-induced structural changes. J. Biol. Chem. 269, 4480-4487 (1994).
97. Schirmer, E. C. & Lindquist, S. Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP. Proc. Natl Acad. Sci. USA 94, 13932-13937 (1997).
98. +]. Mol. Microbiol. 39, 37-46 (2001).
99. -] prion in yeast. Genetics 165, 23-33 (2003).
100. Kushnirov, V. V. & Ter-Avanesyan, M. D. Structure and replication of yeast prions. Cell 94, 13-16 (1998).
101. Newnam, G. P., Wegrzyn, R. D., Lindquist, S. L. & Chernoff, Y. O. Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing. Mol. Cell. Biol. 19, 1325-1333 (1999).
102. -] prion propagation and PSI+ as a cellular stress. Genetics 156, 559-570 (2000).
103. +]. Genetics 163, 495-506 (2003).
104. Ness, F., Ferreira, P., Cox, B. S. & Tuite, M. F. Guanidine hydrochloride inhibits the generation of prion 'seeds' but not prion protein aggregation in yeast. Mol. Cell. Biol. 22, 5593-5605 (2002).
105. Chernoff, Y. O., Newnam, G. P., Kumar, J., Allen, K. & Zink, A. D. Evidence for a protein mutator in yeast: Role of the Hsp70-related chaperone Ssb in formation, stability, and toxicity of the PSI prion. Mol. Cell. Biol. 19, 8103-8112 (1999).
106. -] prion-curing factor. Curr. Genet. 39, 62-67 (2001).
107. Chernoff, Y. O. et al. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein. Mol. Microbiol. 35, 865-876 (2000).
108. Kryndushkin, D. S., Smirnov, V. N., Ter-Avanesyan, M. D. & Kushnirov, V. V. Increased expression of Hsp40 chaperones, transcriptional factors, and ribosomal protein Rpp0 can cure yeast prions. J. Biol. Chem. 277, 23702-23708 (2002).
109. -] and their prion-specific effects. Curr. Biol. 10, 1443-1446 (2000).
110. Bradley, M. E., Edskes, H. K., Hong, J. Y., Wickner, R. B. & Liebman, S. W. Interactions among prions and prion 'strains' in yeast. Proc. Natl Acad. Sci. USA 99, 16392-16399 (2002).
111. +] prion. EMBO J. 20, 2435-2442 (2001).
112. Bailleul, P. A., Newnam, G. P., Steenbergen, J. N. & Chernoff, Y. O. Genetic study of interactions between the cytoskeletal assembly protein sla1 and prion-forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae. Genetics 153, 81-94 (1999).
113. Holtzman, D. A., Yang, S. & Drubin, D. G. Synthetic-lethal interactions identify two novel genes, SLA1 and SLA2, that control membrane cytoskeleton assembly in Saccharomyces cerevisiae. J. Cell Biol. 122, 635-644 (1993).
114. Oka, M. et al. Loss of Hsp70-Hsp40 chaperone activity causes abnormal nuclear distribution and aberrant microtubule formation in M-phase of Saccharomyces cerevisiae. J. Biol. Chem. 273, 29727-29737 (1998).
115. Singh, A., Helms, C. & Sherman, F. Mutation of the non-Mendelian suppressor, Psi+, in yeast by hypertonic media. Proc. Natl Acad. Sci. USA 76, 1952-1956 (1979).
116. +] determinant is not nucleic-acid based.
117. Bailleul-Winslett, P. A., Newnam, G. P., Wegrzyn, R. D. & Chernoff, Y. O. An antiprion effect of the anticytoskeletal drug latrunculin A in yeast. Gene Expr. 9, 145-156 (2000).
118. +] state.
119. -] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol. Microbiol. 40, 1357-1369 (2001).
120. Jung, G. M. & Masison, D. C. Guanidine hydrochloride inhibits Hsp104 activity in vivo: A possible explanation for its effect in curing yeast prions. Curr. Microbiol. 43, 7-10 (2001).
121. Jung, G. M., Jones, G. & Masison, D. C. Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-curing by guanidine, prion propagation, and thermotolerance. Proc. Natl Acad. Sci. USA 99, 9936-9941 (2002).
122. Scheibel, T. et al. Conducting nanowires built by controlled self-assembly of amyloid fibers and selective metal deposition. Proc. Natl Acad. Sci. USA 100, 4527-4532 (2003).
123. Jarrett, J. T. & Lansbury, P. T. Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058 (1993).
124. Chernoff, Y. O., Derkach, I. L. & Ingevechtomov, S. G. Multicopy Sup35 gene induces de novo appearance of Psi-like factors in the yeast Saccharomyces cerevisiae. Curr. Genet. 24, 268-270 (1993).
125. Ter-Avanesyan, M. D. et al. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol. Microbiol. 7, 683-692 (1993).
126. Bousset, L., Belrhali, H., Melki, R. & Morera, S. Crystal structures of the yeast prion Ure2p functional region in complex with glutathione and related compounds. Biochemistry 40, 13564-13573 (2001).
127. Coschigano, P. W. & Magasanik, B. The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione S-transferases. Mol. Cell. Biol. 11, 822-832 (1991).
128. Perrett, S., Freeman, S. J., Butler, P. J. & Fersht, A. R. Equilibrium folding properties of the yeast prion protein determinant Ure2. J. Mol. Biol. 290, 331-345 (1999).
129. Thual, C. et al. Stability, folding, dimenzation, and assembly properties of the yeast prion Ure2p. Biochemistry 40, 1764-1773 (2001).
130. Edskes, H. K., Gray, V. T. & Wickner, R. B. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc. Natl Acad. Sci. USA 96, 1498-1503 (1999).
131. -] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J. Biol. Chem. Sep 24 2003 (doi:10.1074).